Detalles de la búsqueda
1.
ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO.
Ann Surg
; 273(3): 442-448, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32049675
2.
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
Ann Surg
; 269(1): 120-126, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549012
3.
ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial).
Ann Surg
; 267(5): 833-840, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28902669
4.
Response to Comment on: Hasselgren K, et al ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448.
Ann Surg
; 276(5): e632-e633, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129514
5.
Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
Ann Surg Oncol
; 24(8): 2113-2121, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28258416
6.
Response to Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM - It Is Time to Entry the IDEAL Stage 4?"
Ann Surg
; 274(6): e731-e732, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234782
7.
Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy".
Ann Surg
; 274(6): e750-e751, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32590545
8.
Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.
J Surg Oncol
; 114(6): 757-763, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27471127
9.
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
Acta Oncol
; 55(3): 265-77, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26213211
10.
Response to the Comment on "Should We Have a Little More Patience With the Conventional 2-Stage Hepatectomy?"
Ann Surg
; 269(3): e33-e34, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29557882
11.
Response to "ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases".
Ann Surg
; 269(1): e16-e17, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30247325
12.
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.
NPJ Genom Med
; 6(1): 59, 2021 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262039
13.
The expressed mutational landscape of microsatellite stable colorectal cancers.
Genome Med
; 13(1): 142, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34470667
14.
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Genome Med
; 13(1): 143, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34470666
15.
Proximal signaling responses in peripheral T cells from colorectal cancer patients are affected by high concentrations of circulating prostaglandin E2.
Hum Immunol
; 78(2): 129-137, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27769746
16.
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner.
Cancer Immunol Immunother
; 57(6): 813-21, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17962941
Resultados
1 -
16
de 16
1
Próxima >
>>